Physician profile
James B Mark
NPI 1164443545
$7,355.66
in general payments reported to CMS, 2019-2025
9 companies · $2,432 in 2025
The $2,432 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $86.88 · 2021: $378 · 2023: $2,260 · 2024: $1,226 · 2025: $2,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,308 · Food and Beverage: $1,610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,308.08 |
| Food and Beverage | $1,609.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,418.64 | 2019-2025 | Comprehensive Shoulder System, Oxford, Persona |
| Prodigy Surgical Distribution, INC. | $1,615.27 | 2023 | |
| Arthrex, INC. | $1,041.16 | 2023-2025 | |
| Stryker Corporation | $156.82 | 2025 | Tornier Perform Reversed Glenoid, Insignia, Variax |
| Djo, LLC | $32.25 | 2021 | |
| Medela LLC | $29.68 | 2020 | |
| Horizon Therapeutics Plc | $26.79 | 2019 | |
| Fidia Pharma USA INC. | $19.28 | 2025 | Triluron, Hymovis |
| Amgen INC. | $15.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.